These are not FDA-approved for weight loss and exist in a different regulatory category, but they represent options that some researchers explore as alternatives or adjuncts to tirzepatide
The FDA has approved injectable tirzepatide for weight management
Furthermore, it is being investigated for its potential use in chronic weight management, reducing the risk of major adverse cardiovascular events, and managing other conditions such as heart failure with preserved ejection fraction, obesity, and non-cirrhotic non-alcoholic steatohepatitis.The Phase 3 SURPASS 1-5 clinical trial program was conducted to evaluate the safety and effectiveness of tirzepatide, which was administered once weekly through subcutaneous injections at different doses (5, 10, and 15 mg)
Our team of experts can provide you with valuable insights into Tirzepatides mechanism of action, clinical trials, efficacy, safety, dosage, and side effects
This approach helps patients feel more informed while keeping the provider at the center of treatment decisions